3,5-Dicaffeoylquinic acid isolated from Artemisia argyi and its ester derivatives exert anti-Leucyl-tRNA synthetase of Giardia lamblia (GlLeuRS) and potential anti-giardial effects

Fitoterapia

Volumn 83, Issue 7, 2012, Pages 1281-1285

  Zhang, Yan Hong ^a   Xue, Mei Qin ^b   Bai, Yuan Chao ^a   Yuan, Hui Hui ^a   Zhao, Hong Li ^a   Lan, Min Bo ^a,c  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c East China University of Science and Technology   (China)

Author keywords

3,5 Dicaffeoylquinic acid; Anti giardial; Artemisia argyi; Derivatives; Leucyl tRNA synthetase

Indexed keywords

3,5 DICAFFEOYLQUINIC ACID ETHYL ESTER; 3,5 DICAFFEOYLQUINIC ACID METHYL ESTER; 3,5 DICAFFEOYLQUINIC ACID PROPYL ESTER; ANTIPROTOZOAL AGENT; DIMETHYL SULFOXIDE; ISOCHLOROGENIC ACID; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTEMISIA; ARTEMISIA ARGYI; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; ESTERIFICATION; GIARDIA LAMBLIA; IC 50; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

AMINOACYLATION; ANTIPROTOZOAL AGENTS; ARTEMISIA; CHLOROGENIC ACID; GIARDIA LAMBLIA; LEUCINE-TRNA LIGASE; PARASITIC SENSITIVITY TESTS; PLANT EXTRACTS;

ARTEMISIA ARGYI; GIARDIA INTESTINALIS;

EID: 84865461034     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2012.05.016     Document Type: Article

References (31)

1. C.Z. Chen, L. Kulakova, N. Southall, J.J. Marugan, A. Galkin, and C.P. Austin High-throughput Giardia lamblia viability assay using bioluminescent ATP content measurements Antimicrob Agents Chemother 55 2011 667 675
2. J.A. Upcroft, P. Upcroft, and P.F.L. Boreham Drug resistance in Giardia intestinalis Int J Parasitol 20 1990 489 496
3. J.M. Wright, L.A. Dunn, P. Upcroft, and J.A. Upcroft Efficacy of antigiardial drugs Expert Opin Drug Saf 2 2003 529 541
4. O. Nureki, D.G. Vassylyev, M. Tateno, A. Shimada, T. Nakama, and S. Fukai Enzyme structure with two catalytic sites for double-sieve selection of substrate Science 280 1998 578 582
5. E. Seiradake, W. Mao, V. Hernandez, S.J. Baker, J.J. Plattner, and M.R.K. Alley Crystal structures of the human and fungal cytosolic Leucyl-tRNA synthetase editing domains: a structural basis for the rational design of antifungal benzoxaboroles J Mol Biol 390 2009 196 207
6. F.L. Rock, W. Mao, A. Yaremchuk, M. Tukalo, T. Crépin, and H.C. Zhou An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site Science 316 2007 1759 1761
7. X. Hui, S.J. Baker, R.C. Wester, S. Barbadillo, A.K. Cashmore, and V. Sanders In vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate J Pharm Sci 96 2007 2622 2631
8. X.L. Zhou, M. Tan, M. Wang, X. Chen, and E.D. Wang Post-transfer editing by a eukaryotic leucyl-tRNA synthetase resistant to the broad-spectrum drug AN2690 Biochem J 430 2010 325 333
9. X.L. Zhou, B. Zhu, and E.D. Wang The CP2 domain of leucyl-tRNA synthetase is crucial for amino acid activation and post-transfer editing J Biol Chem 283 2008 36608 36616
10. M. Tan, B. Zhu, X.L. Zhou, R. He, X. Chen, and G. Eriani tRNA-dependent pre-transfer editing by prokaryotic leucyl-tRNA synthetase J Biol Chem 285 2010 3235 3244
11. E. Bénéré, R.A. Da Luz, M. Vermeersch, P. Cos, and L. Maes A new quantitative in vitro microculture method for Giardia duodenalis trophozoites J Microbiol Methods 71 2007 101 106
12. D. Lakshmanan, J. Werngren, L. Jose, K.P. Suja, M.S. Nair, and R.L. Varma Ethyl p-methoxycinnamate isolated from a traditional anti-tuberculosis medicinal herb inhibits drug resistant strains of Mycobacterium tuberculosis in vitro Fitoterapia 82 2011 757 761
13. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paull, and D. Vistica Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines J Natl Cancer Inst 83 1991 757 766
14. C.W. Beninger, M.M. Abou-Zaid, A.L.E. Kistner, R.H. Hallett, M.J. Iqbal, and B. Grodzinski A flavanone and two phenolic acids from Chrysanthemum morifolium with phytotoxic and insect growth regulating activity J Chem Ecol 30 2004 589 606
15. M. Chen, W.W. Wu, G.Q. Shen, S.Q. Luo, and H.T. Li Chemical constituents of Lonicera magranthoides hand. -Mazz part V. Isolation and structures of macranthoin F and G Acta Pharm Sin 29 1994 617 620
16. M. Yoshimoto, S. Yahara, S. Okuno, M.S. Islam, K. Ishiguro, and O. Yamakawa Antimutagenicity of mono-, di-, and tricaffeoylquinic acid derivatives isolated from sweetpotato (Lpomoea batatas L.) leaf Biosci Biotechnol Biochem 66 2002 2336 2341
17. J.X. Dong, Z.M. Tang, Z.B. Mi, and B.B. Wang The new use of dicaffeoylquinic acid for treating Hepatitis B and the diseases related with retrovirus, and the new dicaffeoylquinic acid derivatives 2000 EP1008344
18. J.X. Dong, Z.M. Tang, Z.B. Mi, and B.B. Wang Dicaffeoylquinic acid for treating Hepatitis B and the diseases associated with retrovirus, and the new dicaffeoylquinic acid derivatives 2001 US6331565
19. K. Zhu, M.L. Cordeiro, J. Atienza, W.E. Robinson, and S.A. Chow Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids J Virol 73 1999 3309 3316
20. W.E. Robinson, M. Cordeiro, S. Abdel-Malek, Q. Jia, S.A. Chow, and M.G. Reinecke Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase Mol Pharmacol 50 1996 846 855
21. D.C. Crosby, and W.E. Robinson Dicaffeoyltartaric acid and dicaffeoylquinic acid HIV integrase inhibitors, HIV-1 integrase, mechanism and inhibitor design N. Neamati, 2011 John Wiley & Sons, Inc. Hoboken 341 362
22. J.Y. Kim, J.Y. Cho, Y.K. Ma, K.Y. Park, S.H. Lee, and K.S. Ham Dicaffeoylquinic acid derivatives and flavonoid glucosides from glasswort (Salicornia herbacea L.) and their antioxidative activity Food Chem 125 2011 55 62
23. M. Ohnishi, H. Morishita, H. Iwahashi, S. Toda, Y. Shirataki, and M. Kimura Inhibitory effects of chlorogenic acids on linoleic acid peroxidation and haemolysis Phytochemistry 36 1994 579 583
24. L.S.M. Ooi, H. Wang, Z. He, and V.E.C. Ooi Antiviral activities of purified compounds from Youngia japonica (L.) DC (Asteraceae, Compositae) J Ethnopharmacol 106 2006 187 191
25. A.M. Abeysekera, K.T.D. De Silva, S.R.P. De Silva, V.D.P. Sirimanne, R.P. Labadie, and A.J.J. Van Den Berg Inhibition of chemiluminescence generated by zymosan-activated polymorphonuclear leucocytes by phenolic constituents of Vernonia cinerea Fitoterapia 70 1999 317 319
26. F. Calzada, R. Cedillo-Rivera, R. Bye, and R. Mata Geranins C and D, additional new antiprotozoal A-type proanthocyanidins from Geranium niveum Planta Med 67 2001 677 680
27. F. Calzada, C. Velázquez, R. Cedillo-Rivera, and B. Esquivel Antiprotozoal activity of the constituents of Teloxys graveolens Phytother Res 17 2003 731 732
28. F. Calzada, and A.D. Alanis Additional antiprotozoal flavonol glycosides of the aerial parts of Helianthemum glomeratum Phytother Res 21 2007 78 80
29. J.P. Anthony, L. Fyfe, D. Stewart, G.J. Mcdougall, and H.V. Smith The effect of blueberry extracts on Giardia duodenalis viability and spontaneous excystation of Cryptosporidium parvum oocysts, in vitro Methods 42 2007 339 348
30. J.P. Anthony, L. Fyfe, D. Stewart, and G.J. Mcdougall Differential effectiveness of berry polyphenols as anti-giardial agents Parasitology 138 2011 1110 1116
31. E.A. Palombo Phytochemicals from traditional medicinal plants used in the treatment of diarrhoea: modes of action and effects on intestinal function Phytother Res 20 2006 717 724